Literature DB >> 12705631

Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma.

Nu-man Tsai1, Bing-Mae Chen, Shao-Lun Wei, Cheng-Wen Wu, Steve R Roffler.   

Abstract

Cancer metastasis involves distinct steps that depend on complicated tumor-host interactions. The hematogenous dissemination of tumor cells may be facilitated by factors that promote the arrest and adherence of cancer cells in capillaries. We examined whether anti-tumor monoclonal immunoglobulin M (IgM) antibodies promoted the hematogenous dissemination of B16 melanoma cells in syngeneic mice. IgM monoclonal antibodies were generated that selectively bind to B16 melanoma cells as compared to syngeneic fibroblasts, lymphocytes or Lewis lung carcinoma cells. Incubation of B16-BL6 or B16-F0 melanoma cells with these IgM anti-tumor antibodies significantly increased the number of lung colonies as compared with control antibodies. Moreover, intraperitoneal injection of specific antibody also significantly increased lung colonization. All anti-tumor antibodies promoted the aggregation of B16 melanoma cells. A chemically generated immunoglobulin G (IgG)-like fragment of an anti-tumor IgM antibody displayed greatly reduced tumor aggregation and, in contrast to intact IgM, did not significantly increase lung colonization of B16 melanoma cells. Neither intact IgM nor the IgG-like fragment enhanced the in vitro invasiveness of B16 melanoma cells across Matrigel-coated membranes. Our results, therefore, suggest that besides their beneficial anti-tumor effects, anti-tumor IgM antibodies may also promote the hematogenous dissemination of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705631     DOI: 10.1023/a:1022616223359

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

1.  Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

Authors:  S von Mensdorff-Pouilly; A A Verstraeten; P Kenemans; F G Snijdewint; A Kok; G J Van Kamp; M A Paul; P J Van Diest; S Meijer; J Hilgers
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Method for quantitating tumor cell removal and tumor cell-invasive capacity in experimental metastases.

Authors:  L A Liotta; C DeLisi
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

Review 3.  Both IgM and IgG anti-VSG antibodies initiate a cycle of aggregation-disaggregation of bloodstream forms of Trypanosoma brucei without damage to the parasite.

Authors:  C O'Beirne; C M Lowry; H P Voorheis
Journal:  Mol Biochem Parasitol       Date:  1998-03-01       Impact factor: 1.759

4.  Carcinoma of the colon and rectum: circulating malignant cells and five-year survival.

Authors:  J D Griffiths; J A McKinna; H D Rowbotham; P Tsolakidis; A J Salsbury
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

5.  Characterization of a human macroglobulin. II. Distribution of the disulfide bonds.

Authors:  F Miller; H Metzger
Journal:  J Biol Chem       Date:  1965-12       Impact factor: 5.157

Review 6.  General mechanisms of metastasis.

Authors:  E C Woodhouse; R F Chuaqui; L A Liotta
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

7.  Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.

Authors:  N P Parratto; J M Odebralski; A K Kimura
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

8.  Differential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies.

Authors:  M Capurro; C Ballaré; L Bover; P Portela; J Mordoh
Journal:  Cancer Immunol Immunother       Date:  1999 May-Jun       Impact factor: 6.968

9.  Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.

Authors:  M S Kaminski; K Kitamura; D G Maloney; R Levy
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

10.  The "hot spleen" phenomenon in metastatic malignant melanoma: its incidence and relationship with the immune system.

Authors:  J Wagstaff; K Phadke; N Adam; N Thatcher; D Crowther
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860

View more
  1 in total

1.  Mimicking the germinal center reaction in hybridoma cells to isolate temperature-selective anti-PEG antibodies.

Authors:  Yu-Cheng Su; Talal S Al-Qaisi; Hsin-Yi Tung; Tian-Lu Cheng; Kuo-Hsiang Chuang; Bing-Mae Chen; Steve R Roffler
Journal:  MAbs       Date:  2014-05-14       Impact factor: 5.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.